According to the new market
research report "Cold Pain
Therapy Market by Product (OTC (Gels,
Sprays, Patches, Cold Packs, Wraps, Pads, and Roll-Ons), Prescription-Based
(Motorized, Non-Motorized Devices), Applications (Musculoskeletal Disorders,
Post-Operative Therapy, Sports Medicine, and Post-Trauma Therapy) - Global
Forecast to 2023", published by MarketsandMarkets™,
the Global Cold Pain Therapy Market is projected
to reach USD 2.12 Billion by 2023 from USD 1.69 Billion in 2018, at a CAGR of
4.6% during the forecast period.
Factors such as the increasing incidence of sports
injuries and a rising emphasis on exercise, the growing number of hip and knee surgeries
across the globe, and a rising need for safer pain management modalities (as
compared to oral therapy) are expected to drive the demand for cold pain
therapy during the study period.
The OTC products segment is expected to register the
highest growth rate during the forecast period
Based on product, the Cold Pain Therapy Market is divided
into OTC products and prescription products. OTC products are expected to grow
at the highest CAGR during the forecast period. The high patient preference for
topical pharmaceuticals as compared to oral medications, owing to their lower
side effects, fast pain relief, and convenience, is expected to drive the
growth of the OTC products segment in the next five years.
106 - Tables
126 - Figures
273 - Pages
Musculoskeletal disorders are estimated to form the
largest segment of the market, by application
The Cold Pain Therapy Market is segmented, by
application, into musculoskeletal disorders, post-operative therapy, sports
medicine, and post-trauma therapy. The musculoskeletal disorders segment is
expected to account for the largest share of the Cold Pain Therapy Market in
2018, owing to the increasing incidence of arthritis, osteoarthritis, back
pain, and joint pain; increasing trend of self-care; and the growing preference
for topical analgesics to manage musculoskeletal pain.
In 2017, North America accounted for the largest share of
the Cold Pain Therapy Market
Geographically, the Cold Pain Therapy Market is segmented
into North America, Europe, Asia Pacific, and the Rest of the World. North
America accounted for the largest share of the market in 2017. The growing
geriatric population, the high incidence of arthritis and sports injuries,
product launches, the large number of surgeries, and stringent regulations on
opioid prescription are expected to drive the growth of cold pain therapy
products this region.
Read a Press-Release on “Cold Pain Therapy Market”:
As of 2017, the major players in the Cold Pain Therapy
Market are Sanofi (France), DJO Finance (US), and Pfizer (US). Other players in
this market include 3M (US), Hisamitsu Pharmaceutical (Japan), Johnson &
Johnson (US), Medline Industries (US), Ă–ssur (Iceland), Performance Health
(US), Beiersdorf (Germany) Rohto Pharmaceutical (US), Breg (US), Romsons Group
of Industries (India), Custom Ice (US), and Unexo Life Sciences (India).